Doximity price target raised to $31 from $29 at Truist

Truist raised the firm’s price target on Doximity to $31 from $29 and keeps a Hold rating on the shares. The company reported “strong” Q4 results and issued FY25 outlook that was slightly lower than consensus on revenues but bracketed consensus on adjusted EBITDA, the analyst tells investors in a research note. Investor sentiment on Doximity shares has been relatively mixed recently, and this should be a “good enough” quarter, the firm added.